Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers E > Headlines for Exelixis, Inc. > News item |
Exelixis repays $30 million convertible promissory note
By Jennifer Chiou
New York, May 23 - Exelixis, Inc. announced the full repayment of a $30 million convertible promissory note due to Protein Design Labs, Inc., according to an 8-K filing with the Securities and Exchange Commission.
Exelixis is a South San Francisco, Calif., biotechnology company focused on cancer and other diseases.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.